| 今开：0.0 | 昨收：1.88 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：9.895468E7 |
智通财经APP获悉，英国生物技术公司Redx Pharma plc和美国Jounce Therapeutics Inc(JNCE.US)将合并，成立一家4.25亿美元的实体，专门治疗癌症和纤维化疾病。截至发稿，Jounce盘前涨30.25%，报1.29美元。 两家公司周四表示，Redx股东将以... 网页链接
$Jounce Therapeutics(JNCE)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-23-027685 Size: 7 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027688 Size: 12 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-027692 Size: 6 KB 网页链接
$Jounce Therapeutics(JNCE)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001214659-23-006565 Act: 34 Size: 95 KB 网页链接
$Jounce Therapeutics(JNCE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001276 Act: 33 Size: 1 KB 网页链接
$Jounce Therapeutics(JNCE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001275 Act: 33 Size: 1 KB 网页链接
$Jounce Therapeutics(JNCE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-23-000336 Act: 34 Size: 2 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000111 Size: 20 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000112 Size: 26 KB 网页链接
$Jounce Therapeutics(JNCE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001640455-23-000113 Size: 8 KB 网页链接